The Effect of Roux-en-Y vs. Omega-Loop Gastric Bypass on Liver, Metabolic Parameters, and Weight Loss - Report - MDSpire

The Effect of Roux-en-Y vs. Omega-Loop Gastric Bypass on Liver, Metabolic Parameters, and Weight Loss

  • By

  • Renate Kruschitz

  • Maria Luger

  • Christian Kienbacher

  • Michael Trauner

  • Carmen Klammer

  • Karin Schindler

  • Felix B. Langer

  • Gerhard Prager

  • Michael Krebs

  • Bernhard Ludvik

  • March 22, 2016

  • 0 min

Share

Comparative Outcomes of Roux-en-Y vs Omega-Loop Gastric Bypass on Liver and Metabolic Health

Overview

This study compared the effects of Roux-en-Y gastric bypass and omega-loop gastric bypass on liver function, metabolic markers, and weight loss over 12 months in non-diabetic morbidly obese patients. Both procedures resulted in significant weight reduction and improvements in liver enzymes and insulin resistance, with some differences in the trajectory of liver function tests.

Background

Bariatric surgery is the most effective treatment for morbid obesity, leading to sustained weight loss and reduced mortality. Roux-en-Y gastric bypass is considered the gold standard, while omega-loop gastric bypass is a simpler alternative with promising early results. Bariatric surgery also impacts liver health, often improving non-alcoholic fatty liver disease, but rapid weight loss can sometimes adversely affect the liver. This study aimed to evaluate and compare the short- and medium-term effects of these two procedures on liver and metabolic parameters.

Data Highlights

ParameterRoux-en-Y Gastric BypassOmega-Loop Gastric Bypass
Number of Patients2525
Gender Distribution92% Female88% Male
Mean Age (years)44.6 ± 10.343.8 ± 13.1
Mean Weight (kg)125 ± 18128 ± 24
Mean BMI (kg/m²)45.6 ± 4.145.3 ± 5.3
Follow-up TimepointsBaseline, 3, 6, and 12 months postoperatively

Key Findings

  • Both Roux-en-Y and omega-loop gastric bypass led to significant weight loss over 12 months.
  • Serum liver enzymes (AST, ALT) improved postoperatively in both groups, indicating better liver function.
  • Markers of insulin resistance (HOMA2-IR) and insulin sensitivity (QUICKI) improved significantly after surgery in both groups.
  • Protein and albumin levels remained stable, suggesting preserved nutritional status post-surgery.
  • Differences in liver enzyme trajectories between the two procedures were observed but were not statistically significant after adjustment.

Clinical Implications

Both Roux-en-Y and omega-loop gastric bypass are effective bariatric procedures for achieving weight loss and improving liver and metabolic health in non-diabetic morbidly obese patients. Clinicians can consider omega-loop gastric bypass as a simpler alternative with comparable short-term outcomes. Monitoring liver function and metabolic markers remains important during postoperative follow-up to detect any adverse effects early.

Conclusion

Roux-en-Y and omega-loop gastric bypass procedures both result in substantial weight loss and improvements in liver and metabolic parameters over 12 months. These findings support the use of either technique in appropriate patients, with careful postoperative monitoring.

References

  1. General Hospital Vienna Ethics Committee 2011 -- Study Approval and Registration
  2. Bariatric Surgery Reviews 2011-2013 -- Comparative Studies on Gastric Bypass Procedures

Original Source(s)

Related Content